Voranigo Tablet, Film Coated
Product Images NDC 72694-879

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Voranigo (NDC 72694-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Servier Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Voranigo 01)

FDA Label Image

Figure 1 (Voranigo 02)

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Carton)

Principal Display Panel (10 mg Tablet Bottle Carton)
The text provides information about a medication in tablet form called Voranigo, containing 10 mg of vorasidenib per tablet. It includes instructions to store between 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medicine is manufactured for Servier Pharmaceuticals LLC in Boston, MA. It also mentions child-resistant packaging and states that the recommended dosage should be obtained from prescribing information. The text includes trademark information and details about the tablet packaging.*
FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.